In recent years, a review of the evidence indicates that high expression of PKM2 has been observed in numerous cancers, such as hilar cholangiocarcinoma, lung cancer, gastric cancer and colorectal cancers21–24. This evidence concerns the gene PKM and hilar cholangiocarcinoma.